These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533 [Abstract] [Full Text] [Related]
23. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction. Kasuya K, Nagakawa Y, Matsudo T, Ozawa T, Tsuchida A, Aoki T, Itoi T, Itokawa F. J Hepatobiliary Pancreat Surg; 2009 Jan; 16(3):376-81. PubMed ID: 19183832 [Abstract] [Full Text] [Related]
25. Relationship between types of common channel and development of biliary tract cancer in pancreaticobiliary maljunction. Hara H, Morita S, Sako S, Dohi T, Otani M, Iwamoto M, Inoue H, Tanigawa N. Hepatogastroenterology; 2002 Jan; 49(44):322-5. PubMed ID: 11995442 [Abstract] [Full Text] [Related]
26. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [Abstract] [Full Text] [Related]
27. Clinical and pathological features of primary carcinoma of the cystic duct. Nakata T, Kobayashi A, Miwa S, Soeda J, Uehara T, Miyagawa S. J Hepatobiliary Pancreat Surg; 2009 Jun; 16(1):75-82. PubMed ID: 19096752 [Abstract] [Full Text] [Related]
28. Importance of early diagnosis of pancreaticobiliary maljunction without biliary dilatation. Takuma K, Kamisawa T, Tabata T, Hara S, Kuruma S, Inaba Y, Kurata M, Honda G, Tsuruta K, Horiguchi S, Igarashi Y. World J Gastroenterol; 2012 Jul 14; 18(26):3409-14. PubMed ID: 22807610 [Abstract] [Full Text] [Related]
29. [A national survey of 1098 cases with extrahepatic biliary cancer]. Zhonghua Wai Ke Za Zhi; 1990 Sep 14; 28(9):516-21, 572. PubMed ID: 2086121 [Abstract] [Full Text] [Related]
30. Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development. Seki M, Yanagisawa A, Ninomiya E, Ninomiya Y, Ohta H, Saiura A, Yamamoto J, Yamaguchi T, Aruga A, Yamada K, Takano K, Fujita R, Ikeda M, Sasaki K, Kato Y. J Hepatobiliary Pancreat Surg; 2005 Sep 14; 12(3):254-62. PubMed ID: 15995816 [Abstract] [Full Text] [Related]
31. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002. Goodman MT, Yamamoto J. Cancer Causes Control; 2007 May 14; 18(4):415-22. PubMed ID: 17264972 [Abstract] [Full Text] [Related]
32. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. Masuhara S, Kasuya K, Aoki T, Yoshimatsu A, Tsuchida A, Koyanagi Y. J Hepatobiliary Pancreat Surg; 2000 May 14; 7(2):198-205. PubMed ID: 10982614 [Abstract] [Full Text] [Related]
33. Pancreaticobiliary maljunction. Kamisawa T, Takuma K, Anjiki H, Egawa N, Kurata M, Honda G, Tsuruta K, Sasaki T. Clin Gastroenterol Hepatol; 2009 Nov 14; 7(11 Suppl):S84-8. PubMed ID: 19896105 [Abstract] [Full Text] [Related]
34. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S. World J Surg; 2002 Jan 14; 26(1):91-8. PubMed ID: 11898040 [Abstract] [Full Text] [Related]
35. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Albores-Saavedra J, Batich K, Hossain S, Henson DE, Schwartz AM. Ann Diagn Pathol; 2009 Dec 14; 13(6):378-83. PubMed ID: 19917473 [Abstract] [Full Text] [Related]
36. Papillary carcinoma of the extrahepatic bile duct: characteristic features and implications in surgical treatment. Okamoto A, Tsuruta K, Matsumoto G, Takahashi T, Kamisawa T, Egawa N, Funata N. J Am Coll Surg; 2003 Mar 14; 196(3):394-401. PubMed ID: 12648691 [Abstract] [Full Text] [Related]
37. Recent advances and problems in the management of pancreaticobiliary maljunction: feedback from the guidelines committee. Kamisawa T, Ando H, Shimada M, Hamada Y, Itoi T, Takayashiki T, Miyazaki M. J Hepatobiliary Pancreat Sci; 2014 Feb 14; 21(2):87-92. PubMed ID: 23798483 [Abstract] [Full Text] [Related]
38. Surgical treatment for congenital biliary dilatation, with or without intrahepatic bile duct dilatation. Hara H, Morita S, Ishibashi T, Sako S, Otani M, Tanigawa N. Hepatogastroenterology; 2001 Feb 14; 48(39):638-41. PubMed ID: 11462892 [Abstract] [Full Text] [Related]
39. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system. Hori H, Ajiki T, Fujita T, Okazaki T, Suzuki Y, Kuroda Y, Fujimori T. Jpn J Clin Oncol; 2006 Oct 14; 36(10):638-42. PubMed ID: 16908513 [Abstract] [Full Text] [Related]
40. Is preventive resection of the extrahepatic bile duct necessary in cases of pancreaticobiliary maljunction without dilatation of the bile duct? Aoki T, Tsuchida A, Kasuya K, Endo M, Kitamura K, Koyanagi Y. Jpn J Clin Oncol; 2001 Mar 14; 31(3):107-11. PubMed ID: 11336321 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]